ReNeuron Signs Manufacturing Contract With Angel Biotechnology Ltd For Its ReN005 Stem Cell Line For Huntington’s Disease

ReNeuron Group plc (LSE: RENE.L) today announced that it has signed a manufacturing contract with Angel Biotechnology Holdings plc, the UK biopharmaceutical contract manufacturer.
MORE ON THIS TOPIC